Meeder Asset Management Inc Ani Pharmaceuticals Inc Transaction History

Meeder Asset Management Inc

$1.48 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$29.83 - $38.01 $29 - $38	1 Added 50.0%	3 $0
Q2 2022 Aug 08, 2022	SELL	$23.09 - $33.46 $369 - $535	-16 Reduced 88.89%	2 $0
Q1 2022 May 10, 2022	BUY	$26.91 - $47.15 $484 - $848	18 New	18 $1,000
Q4 2021 Feb 11, 2022	SELL	$32.97 - $56.85 $45,894 - $79,135	-1,392 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$26.48 - $35.99 $36,251 - $49,270	1,369 Added 5952.17%	1,392 $45,000
Q1 2021 Apr 28, 2021	SELL	$28.4 - $36.14 $113 - $144	-4 Reduced 14.81%	23 $1,000
Q4 2020 Feb 09, 2021	BUY	$23.69 - $31.47 $47 - $62	2 Added 8.0%	27 $1,000
Q3 2020 Nov 02, 2020	BUY	$26.38 - $33.1 $606 - $761	23 Added 1150.0%	25 $1,000
Q2 2020 Aug 11, 2020	SELL	$29.93 - $50.1 $867 - $1,452	-29 Reduced 93.55%	2 $0
Q1 2020 May 15, 2020	SELL	$30.35 - $67.14 $59,759 - $132,198	-1,969 Reduced 98.45%	31 $1,000
Q4 2019 Feb 13, 2020	BUY	$55.65 - $79.83 $110,187 - $158,063	1,980 Added 9900.0%	2,000 $125,000
Q3 2019 Oct 17, 2019	SELL	$64.7 - $85.39 $164,855 - $217,573	-2,548 Reduced 99.22%	20 $1,000
Q2 2019 Aug 05, 2019	BUY	$67.77 - $82.2 $174,033 - $211,089	2,568 New	2,568 $211,000
Q4 2018 Jan 17, 2019	SELL	$41.17 - $56.44 $288 - $395	-7 Closed	0 $0
Q3 2018 Nov 02, 2018	SELL	$52.95 - $71.34 $8,207 - $11,057	-155 Reduced 95.68%	7 $0
Q2 2018 Jul 24, 2018	SELL	$56.38 - $68.08 $169 - $204	-3 Reduced 1.82%	162 $0
Q1 2018 May 03, 2018	SELL	$56.98 - $72.41 $3,532 - $4,489	-62 Reduced 27.31%	165 $10,000
Q4 2017 Feb 02, 2018	BUY	$53.3 - $74.56 $10,660 - $14,912	200 Added 740.74%	227 $14,000
Q3 2017 Oct 20, 2017	BUY	$43.46 - $52.49 $1,173 - $1,417	27	27 $1,000

Others Institutions Holding ANIP

# of Institutions

211

Shares Held

18.8M

Call Options Held

11.7K

Put Options Held

10.5K

View Full List

About ANI PHARMACEUTICALS INC

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $1.02B
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

More about ANIP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.

Account